GLYCOPHOS FDA approval date

The FDA approved GLYCOPHOS on 29 Jul 2026.

FDA approval date
29 Jul 2026

Drug identity has not yet been verified against registry records

Also recorded as SODIUM GLYCEROPHOSPHATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-07-29DayGLYCOPHOSFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220381", "applicant_as_listed_by_fda": "FRESENIUS KABI USA", "brand_names": ["GLYCOPHOS"], "active_ingredients": ["SODIUM GLYCEROPHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260729", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026